Contraceptive vaginal ring releasing etonogestrel and ethinylestradiol (NuvaRing): Cycle control, acceptability and tolerability study in Indian women.

Trial Profile

Contraceptive vaginal ring releasing etonogestrel and ethinylestradiol (NuvaRing): Cycle control, acceptability and tolerability study in Indian women.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 09 Oct 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 25 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Aug 2012 Planned end date changed from 1 Oct 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top